Next Generation Flow Cytometry (NGFC) plays an important role in diagnostics, providing a highly sensitive method to generate reliable data of clinical relevance in different plasma cell (PC) dyscrasias. Recent studies showed the presence of MM tumor malignant cells in peripheral blood, which can be detected and quantified by using NGFC, providing additional prognostic information.
In this webinar, Dr. Paula Tabares will describe the flow-based method for detection of CTPC in peripheral blood and the benefit of assessing CTPC in the clinical routine.
Monitoring Circulating Plasma Cells in routine diagnostics in Multiple Myeloma
